SHENYANG, China, Sept. 18 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. , a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that the Annual General Meeting of Shareholders of 3SBio Inc. will be held at 10:00 am (Beijing) on Wednesday, October 17, 2007 at Tower B-13, Grand Place, 5 Huizhong Road Chaoyang Disctrict, Beijing, People’s Republic of China 100101.
Further information is available at http://www.3sbio.com or on 3SBio’s annual report on Form 20-F, which can be accessed at: http://3sbio.ir.edgar- online.com/fetchFilingFrameset.aspx?FilingID=5272154&Type=HTML
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, primarily in China. For more information, please visit 3SBio on the web at http://www.3sbio.com .
For more information, please contact: Investor Contact: Clara Mak, CFO 3SBio Inc. Phone: +86-24-2581-1820 Investor Relations (HK): Ruby Yim Taylor Rafferty Phone: +852-3196-3712 Investor Relations (US): Mahmoud Siddig Taylor Rafferty Phone: +1-212-889-4350 Media Contact: John Dooley Taylor Rafferty Phone: +1-212-889-4350
3SBio Inc.
CONTACT: Investor Contact: Clara Mak, CFO of 3SBio Inc., Phone: +86-24-2581-1820; Investor Relations (HK): Ruby Yim of Taylor Rafferty, Phone:+852- 3196-3712; Investor Relations (US): Mahmoud Siddig of TaylorRafferty, Phone: +1-212-889-4350; Media Contact: John Dooley of TaylorRafferty, Phone: +1-212- 889-4350
